Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary reveals a decline in key financial metrics: revenue decreased by 5%, gross margin declined by 2 percentage points, operating expenses increased by 10%, and net income decreased by 15%. These factors are compounded by a 20% decline in cash flow from operations. The lack of strategic initiatives or positive operational updates further supports a negative sentiment. Given the company's market cap, the stock price is likely to react negatively, falling within the -2% to -8% range over the next two weeks.
Key Financial Performance
Revenue $350 million, a decrease of 5% year-over-year, primarily due to lower demand in international markets.
Gross Margin 55%, a decline of 2 percentage points year-over-year, attributed to increased production costs.
Operating Expenses $150 million, an increase of 10% year-over-year, driven by higher R&D investments and marketing expenses.
Net Income $50 million, a decrease of 15% year-over-year, due to higher operating expenses and lower revenue.
Cash Flow from Operations $60 million, a decline of 20% year-over-year, impacted by lower net income and changes in working capital.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: The company acknowledges that actual results and events may differ from projections due to substantial risks and uncertainties.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Allen Lutz
BTIG LLC
Baird Radford
BofA Securities
CEO Nnamdi
COO Stanislav
Division Allen
Division Benchmark
Division Eugene
Division Hewitt
Division Larsen
Division Scott
Division Tassan
Division name
EDT Randall
Eugene Mannheimer
Executive VP
Inc Research
Instructions pleasure
LLC Research
Mannheimer Prime
Omnicell Form
Piper Sandler
Radford Executive
Randall Lipps
Research Division
Sandler Co
Tassan Piper
Tina conference
VP COO
name Tina
pleasure Baird
today Omnicell
OMCL Transcript
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Unknown4-28
The earnings call summary reveals a decline in key financial metrics: revenue decreased by 5%, gross margin declined by 2 percentage points, operating expenses increased by 10%, and net income decreased by 15%. These factors are compounded by a 20% decline in cash flow from operations. The lack of strategic initiatives or positive operational updates further supports a negative sentiment. Given the company's market cap, the stock price is likely to react negatively, falling within the -2% to -8% range over the next two weeks.
Omnicell, Inc. (OMCL) Q4 2025 Earnings Call Transcript
Positive2-5
The earnings call reveals a positive outlook with increased revenue and EPS guidance, improved margins, and strategic investments in product development and market expansion. The Q&A section highlights strong competitive positioning and confidence in new product launches. Although there are some uncertainties, such as the impact of tariff costs and the timeline for new product adoption, the company's proactive strategies and optimistic guidance suggest a positive sentiment. Given the market cap of approximately $1.2 billion, the stock is likely to see a positive reaction, between 2% and 8%, over the next two weeks.
Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call reveals strong financial performance with increased guidance, new product launches, and strategic growth drivers. Despite slight margin declines and cash flow reduction, the company has managed debt well and engaged in stock repurchases. The Q&A highlights positive sentiment towards AI and robotics integration, and a favorable buying environment in hospitals. The reaffirmed guidance and strategic focus on innovative platforms suggest a positive outlook, likely resulting in a 2% to 8% stock price increase given the market cap.
Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript
Positive8-1
The earnings call highlights strong financial metrics, a positive outlook on product development, and strategic market positioning. Despite concerns about tariffs and Medicaid cuts, the company is mitigating risks through supply chain resiliency and innovative solutions. Guidance remains optimistic, particularly with the potential growth of OmniSphere and IV compounding products. The market cap indicates a more pronounced reaction, suggesting a positive stock movement in the short term.
OMCL Slides
Omnicell Q4 2025 slides: EPS miss drives 15% stock drop despite revenue growth2026-02-05
Omnicell Q3 2025 slides: Medication management leader beats estimates, accelerates SaaS growth2025-10-30
Omnicell Q2 2025 slides: Revenue up 5%, shares jump on recurring revenue growth2025-07-31
Omnicell Q1 2025 slides: revenue up 10%, recurring revenue reaches 56% of total2025-05-06
OMCL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
